Skip to main content

Table 4 Proportion of patients with a prescription in one of the ATC main classes

From: Upper gastrointestinal symptoms, psychosocial co-morbidity and health care seeking in general practice: population based case control study

 

Upper GI symptoms

(n = 13,389)

Control patients

(n = 13,389)

Odds ratio

(95% CI)

Alimentary tract and metabolism

92.5

17.3

59.1 (54.7-63.9)

   Excluding drugs for acid related disorders (A02)

32.3

14.1

2.90 (2.73-3.08)

Blood

18.5

13.2

1.50 (1.40-1.60)

Cardiovascular system

34.2

25.6

1.51 (1.44-1.59)

Dermatologicals

32.8

21.4

1.79 (1.70-1.89)

Genito-urinary system and sex hormones

20.4

15.6

1.39 (1.31-1.48)

Systemic hormonal preparations excluding insulin

10.0

6.6

1.59 (1.45-1.73)

Anti-infectives

42.1

30.5

1.66 (1.58-1.74)

Antineoplastic and immunomodulating agents

1.1

0.8

1.44 (1.12-1.85)

Musculoskeletal system

33.9

21.6

1.86 (1.76-1.96)

   NSAIDs* (M01A)

31.5

20.0

1.83 (1.73-1.94)

Nervous system

45.1

26.0

2.34 (2.22-2.46)

Antiparasitic products, insecticides, repellents

1.9

1.0

1.97 (1.59-2.43)

Respiratory system

32.1

20.4

1.84 (1.74-1.95)

Sensory organs

14.8

10.1

1.55 (1.44-1.67)

Various

0.2

0.1

1.93 (1.01-3.68)

  1. ATC-code; including influenza vaccines; *non-steroid anti-inflammatory drugs